The Global Nebulizer Market size is expected to reach $1.4 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period.
A nebulizer, also known as a nebulizer, is a kind of drug delivery equipment that is used in the medical field to provide medicines in the form of a mist that is breathed into the lungs of the patient. Nebulizers are often used in the treatment of a variety of respiratory illnesses and conditions, including asthma, cystic fibrosis, COPD, and others. They employ oxygen, compressed air, or ultrasonic power to break up liquids and suspensions into minute aerosol droplets that are breathed through the mouthpiece of the device. These droplets may be inhaled by the user. A combination of gas with solid or liquid particles is referred to as an aerosol.
Both home (tabletop) and portable versions of nebulizers are available. Nebulizers designed for use in the home are often bigger and need to be plugged into a power source. Nebulizers that are portable may be powered by batteries or plugged into an electrical outlet in a vehicle. Some are just slightly larger than a standard deck of playing cards, making it possible to transport them in a handbag or briefcase.
Within the nebulizer market, it is anticipated that the nebulizer sector will see significant growth. There may be a connection between the shifting manufacturing of nebulizer devices and the easy and inexpensive availability of land in emerging countries. The population of the United States is showing signs of increasing interest in the use of newly created nebulizers that are capable of delivering medications in a timely manner and that also include high-end technological analysis and more accuracy.
The device is able to deliver the drug to a particular location in the lungs, so reducing the dosage and, as a result, the incidental effects of the medication. Additionally, the device is able to detect when the patient is not breathing adequately and send out warning signals. People from all around the globe have a preference for nebulizers that have cutting-edge features and benefits. Following the spread of the coronavirus, there has been an increased interest in taking preventative measures, which has demanded the incorporation of forward-thinking technology such as secure cloud computing that is synchronized with nebulizers for continuous patient monitoring.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Koninklijke Philips N.V., Drive DeVilbiss Healthcare (Medical Depot, Inc.), Beurer GmBH, Vectura Group Plc (Philip Morris International, Inc.), Allied Healthcare Products, Inc., GE HealthCare Technologies, Inc., PARI GmbH, Aerogen Ltd.
A nebulizer, also known as a nebulizer, is a kind of drug delivery equipment that is used in the medical field to provide medicines in the form of a mist that is breathed into the lungs of the patient. Nebulizers are often used in the treatment of a variety of respiratory illnesses and conditions, including asthma, cystic fibrosis, COPD, and others. They employ oxygen, compressed air, or ultrasonic power to break up liquids and suspensions into minute aerosol droplets that are breathed through the mouthpiece of the device. These droplets may be inhaled by the user. A combination of gas with solid or liquid particles is referred to as an aerosol.
Both home (tabletop) and portable versions of nebulizers are available. Nebulizers designed for use in the home are often bigger and need to be plugged into a power source. Nebulizers that are portable may be powered by batteries or plugged into an electrical outlet in a vehicle. Some are just slightly larger than a standard deck of playing cards, making it possible to transport them in a handbag or briefcase.
Within the nebulizer market, it is anticipated that the nebulizer sector will see significant growth. There may be a connection between the shifting manufacturing of nebulizer devices and the easy and inexpensive availability of land in emerging countries. The population of the United States is showing signs of increasing interest in the use of newly created nebulizers that are capable of delivering medications in a timely manner and that also include high-end technological analysis and more accuracy.
The device is able to deliver the drug to a particular location in the lungs, so reducing the dosage and, as a result, the incidental effects of the medication. Additionally, the device is able to detect when the patient is not breathing adequately and send out warning signals. People from all around the globe have a preference for nebulizers that have cutting-edge features and benefits. Following the spread of the coronavirus, there has been an increased interest in taking preventative measures, which has demanded the incorporation of forward-thinking technology such as secure cloud computing that is synchronized with nebulizers for continuous patient monitoring.
COVID-19 Impact Analysis
The pandemic has forced the healthcare sector to adopt emergency measures, including a race to develop therapeutic and preventative treatments. These measures are being taken as a direct result of the pandemic. Patients with asthma or COPD who were aware of the possibility of COVID-19 spreading through the air were apprehensive about using inhaled medications because they are thought to be a potential source of viral transmission and immunosuppression. Patients with asthma or COPD who were not aware of the possibility of COVID-19 spreading through the air were not as concerned. It is projected that the spread of the COVID-19 pandemic would be beneficial to the market for nebulizers.Market Growth Factors
The rising prevalence of respiratory disorders is driving the expansion of the market.
Chronic obstructive pulmonary disease (also known as COPD) is a progressive lung disease that presents a significant risk to the patient's life. It causes shortness of breath (often brought on by physical activity) and puts the patient at risk for catastrophic illness. According to the World Health Organization, it is projected that the illness was responsible for around 3 million fatalities in the world in 2015. This figure represents approximately 5% of all deaths that occurred around the world in 2015. The increasing prevalence of chronic respiratory diseases is driving up consumer demand for nebulizers, which in turn is driving the expansion of the market.Demand on the rise for healthcare delivered in the home.
Due to advances in medicine, the prevalence of communicable illnesses in poor nations has decreased, while the prevalence of non-communicable diseases has increased. The rise in the incidence of lifestyle illnesses may be attributed, in part, to factors such as leading a sedentary lifestyle and drinking excessive amounts of alcohol. As a result, the increasing demand for efficient inhaled medication delivery devices and the marketing of respiratory care devices for use in the home by a large number of healthcare institutions are projected to drive the development of this market throughout the period covered by the estimate.Market Restraining Factor
Nebulizer's potential adverse effects on the user
Nebulized forms of drugs may exhibit their full range of potential adverse effects and interactions. The majority of the adverse effects brought on by nebulizer usage are directly related to the medicine that is being administered. However, if the temperature of the nebulized solution is too high or the composition of the solution is too high (tonicity), this might cause the airway to constrict, which can make it difficult to breathe. If a face mask is not worn properly, it may irritate the user's eyes and cause discomfort. Nebulizers may not be adopted as widely as a result of their potential adverse effects, which would result in a slower growth rate for the market throughout the time being analyzed.Type Outlook
Based on type, the nebulizer market is classified into the jet, mesh, and ultrasonic. The jet segment maintained highest revenue share. This is a result of the inexpensive nature of the gadgets. In addition, the simplicity with which jet nebulizers may be handled and the effectiveness of their design in terms of the administration of drugs has helped to propel this market sector to its current position as the most lucrative one. In contrast to dry powder inhalers and pressurized metered-dose inhalers, jet nebulizers are capable of effectively delivering formulations that cannot be supplied by either of these other types of inhalers.End-use Outlook
Based on end-use, the nebulizers market is segmented into hospitals & clinics, emergency centers, and home healthcare. The home healthcare segment registered the significant revenue share in the market. In recent years, home healthcare gadgets have been increasing their market share as well as their appeal. The miniaturization of items and the progression of technology are two factors that are driving up the demand for home healthcare equipment.Application Outlook
Based on Application, the Nebulizer Market is segregated into cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD), and Others. The chronic obstructive pulmonary disease (COPD) segment had the largest revenue share in 2021. This is because of the rising incidence of COPD in the population. Nebulizers have recently benefited from advancements in technology that have made them more portable and user-friendly for patients. In addition, several kinds of medications, such as long-acting beta2-agonists (LABAs), steroids, long-acting muscarinic receptor antagonists, mucolytics, and antibiotics, are commonly accessible in nebulized formulations.Regional Outlook
Based on region, the nebulizer market is divided into North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region procured the substantial revenue share in the Nebulizer Market in 2021. This is because there is a significant population of elderly people, there is a growing emphasis on preventative care, and there are government efforts that promote technological innovation. The demand for these gadgets has been brought about by a rise in both the region's overall healthcare expenditures and the level of patient awareness.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Koninklijke Philips N.V., Drive DeVilbiss Healthcare (Medical Depot, Inc.), Beurer GmBH, Vectura Group Plc (Philip Morris International, Inc.), Allied Healthcare Products, Inc., GE HealthCare Technologies, Inc., PARI GmbH, Aerogen Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Jet
- Mesh
- Ultrasonic
By End-use
- Hospitals & Clinics
- Emergency Centers
- Home Healthcare
By Application
- COPD
- Asthma
- Cystic Fibrosis
- Others
By Geography
North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Omron Corporation
- Koninklijke Philips N.V
- Drive DeVilbiss Healthcare (Medical Depot, Inc.)
- Beurer GmBH
- Vectura Group Plc (Philip Morris International, Inc.)
- Allied Healthcare Products, Inc
- GE HealthCare Technologies, Inc
- PARI GmbH
- Aerogen Ltd
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Nebulizer Market, by Type
1.4.2 Global Nebulizer Market, by End-use
1.4.3 Global Nebulizer Market, by Application
1.4.4 Global Nebulizer Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Nebulizer Market by Type
3.1 Global Jet Market by Region
3.2 Global Mesh Market by Region
3.3 Global Ultrasonic Market by Region
Chapter 4. Global Nebulizer Market by End-use
4.1 Global Hospitals & Clinics Market by Region
4.2 Global Emergency Centers Market by Region
4.3 Global Home Healthcare Market by Region
Chapter 5. Global Nebulizer Market by Application
5.1 Global COPD Market by Region
5.2 Global Asthma Market by Region
5.3 Global Cystic Fibrosis Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Nebulizer Market by Region
6.1 North America Nebulizer Market
6.1.1 North America Nebulizer Market by Type
6.1.1.1 North America Jet Market by Country
6.1.1.2 North America Mesh Market by Country
6.1.1.3 North America Ultrasonic Market by Country
6.1.2 North America Nebulizer Market by End-use
6.1.2.1 North America Hospitals & Clinics Market by Country
6.1.2.2 North America Emergency Centers Market by Country
6.1.2.3 North America Home Healthcare Market by Country
6.1.3 North America Nebulizer Market by Application
6.1.3.1 North America COPD Market by Country
6.1.3.2 North America Asthma Market by Country
6.1.3.3 North America Cystic Fibrosis Market by Country
6.1.3.4 North America Others Market by Country
6.1.4 North America Nebulizer Market by Country
6.1.4.1 US Nebulizer Market
6.1.4.1.1 US Nebulizer Market by Type
6.1.4.1.2 US Nebulizer Market by End-use
6.1.4.1.3 US Nebulizer Market by Application
6.1.4.2 Canada Nebulizer Market
6.1.4.2.1 Canada Nebulizer Market by Type
6.1.4.2.2 Canada Nebulizer Market by End-use
6.1.4.2.3 Canada Nebulizer Market by Application
6.1.4.3 Mexico Nebulizer Market
6.1.4.3.1 Mexico Nebulizer Market by Type
6.1.4.3.2 Mexico Nebulizer Market by End-use
6.1.4.3.3 Mexico Nebulizer Market by Application
6.1.4.4 Rest of North America Nebulizer Market
6.1.4.4.1 Rest of North America Nebulizer Market by Type
6.1.4.4.2 Rest of North America Nebulizer Market by End-use
6.1.4.4.3 Rest of North America Nebulizer Market by Application
6.2 Europe Nebulizer Market
6.2.1 Europe Nebulizer Market by Type
6.2.1.1 Europe Jet Market by Country
6.2.1.2 Europe Mesh Market by Country
6.2.1.3 Europe Ultrasonic Market by Country
6.2.2 Europe Nebulizer Market by End-use
6.2.2.1 Europe Hospitals & Clinics Market by Country
6.2.2.2 Europe Emergency Centers Market by Country
6.2.2.3 Europe Home Healthcare Market by Country
6.2.3 Europe Nebulizer Market by Application
6.2.3.1 Europe COPD Market by Country
6.2.3.2 Europe Asthma Market by Country
6.2.3.3 Europe Cystic Fibrosis Market by Country
6.2.3.4 Europe Others Market by Country
6.2.4 Europe Nebulizer Market by Country
6.2.4.1 Germany Nebulizer Market
6.2.4.1.1 Germany Nebulizer Market by Type
6.2.4.1.2 Germany Nebulizer Market by End-use
6.2.4.1.3 Germany Nebulizer Market by Application
6.2.4.2 UK Nebulizer Market
6.2.4.2.1 UK Nebulizer Market by Type
6.2.4.2.2 UK Nebulizer Market by End-use
6.2.4.2.3 UK Nebulizer Market by Application
6.2.4.3 France Nebulizer Market
6.2.4.3.1 France Nebulizer Market by Type
6.2.4.3.2 France Nebulizer Market by End-use
6.2.4.3.3 France Nebulizer Market by Application
6.2.4.4 Russia Nebulizer Market
6.2.4.4.1 Russia Nebulizer Market by Type
6.2.4.4.2 Russia Nebulizer Market by End-use
6.2.4.4.3 Russia Nebulizer Market by Application
6.2.4.5 Spain Nebulizer Market
6.2.4.5.1 Spain Nebulizer Market by Type
6.2.4.5.2 Spain Nebulizer Market by End-use
6.2.4.5.3 Spain Nebulizer Market by Application
6.2.4.6 Italy Nebulizer Market
6.2.4.6.1 Italy Nebulizer Market by Type
6.2.4.6.2 Italy Nebulizer Market by End-use
6.2.4.6.3 Italy Nebulizer Market by Application
6.2.4.7 Rest of Europe Nebulizer Market
6.2.4.7.1 Rest of Europe Nebulizer Market by Type
6.2.4.7.2 Rest of Europe Nebulizer Market by End-use
6.2.4.7.3 Rest of Europe Nebulizer Market by Application
6.3 Asia Pacific Nebulizer Market
6.3.1 Asia Pacific Nebulizer Market by Type
6.3.1.1 Asia Pacific Jet Market by Country
6.3.1.2 Asia Pacific Mesh Market by Country
6.3.1.3 Asia Pacific Ultrasonic Market by Country
6.3.2 Asia Pacific Nebulizer Market by End-use
6.3.2.1 Asia Pacific Hospitals & Clinics Market by Country
6.3.2.2 Asia Pacific Emergency Centers Market by Country
6.3.2.3 Asia Pacific Home Healthcare Market by Country
6.3.3 Asia Pacific Nebulizer Market by Application
6.3.3.1 Asia Pacific COPD Market by Country
6.3.3.1.1 Asia Pacific Asthma Market by Country
6.3.3.1.2 Asia Pacific Cystic Fibrosis Market by Country
6.3.3.1.3 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Nebulizer Market by Country
6.3.4.1 China Nebulizer Market
6.3.4.1.1 China Nebulizer Market by Type
6.3.4.1.2 China Nebulizer Market by End-use
6.3.4.1.3 China Nebulizer Market by Application
6.3.4.2 Japan Nebulizer Market
6.3.4.2.1 Japan Nebulizer Market by Type
6.3.4.2.2 Japan Nebulizer Market by End-use
6.3.4.2.3 Japan Nebulizer Market by Application
6.3.4.3 India Nebulizer Market
6.3.4.3.1 India Nebulizer Market by Type
6.3.4.3.2 India Nebulizer Market by End-use
6.3.4.3.3 India Nebulizer Market by Application
6.3.4.4 South Korea Nebulizer Market
6.3.4.4.1 South Korea Nebulizer Market by Type
6.3.4.4.2 South Korea Nebulizer Market by End-use
6.3.4.4.3 South Korea Nebulizer Market by Application
6.3.4.5 Singapore Nebulizer Market
6.3.4.5.1 Singapore Nebulizer Market by Type
6.3.4.5.2 Singapore Nebulizer Market by End-use
6.3.4.5.3 Singapore Nebulizer Market by Application
6.3.4.6 Malaysia Nebulizer Market
6.3.4.6.1 Malaysia Nebulizer Market by Type
6.3.4.6.2 Malaysia Nebulizer Market by End-use
6.3.4.6.3 Malaysia Nebulizer Market by Application
6.3.4.7 Rest of Asia Pacific Nebulizer Market
6.3.4.7.1 Rest of Asia Pacific Nebulizer Market by Type
6.3.4.7.2 Rest of Asia Pacific Nebulizer Market by End-use
6.3.4.7.3 Rest of Asia Pacific Nebulizer Market by Application
6.4 LAMEA Nebulizer Market
6.4.1 LAMEA Nebulizer Market by Type
6.4.1.1 LAMEA Jet Market by Country
6.4.1.2 LAMEA Mesh Market by Country
6.4.1.3 LAMEA Ultrasonic Market by Country
6.4.2 LAMEA Nebulizer Market by End-use
6.4.2.1 LAMEA Hospitals & Clinics Market by Country
6.4.2.2 LAMEA Emergency Centers Market by Country
6.4.2.3 LAMEA Home Healthcare Market by Country
6.4.3 LAMEA Nebulizer Market by Application
6.4.3.1 LAMEA COPD Market by Country
6.4.3.2 LAMEA Asthma Market by Country
6.4.3.3 LAMEA Cystic Fibrosis Market by Country
6.4.3.4 LAMEA Others Market by Country
6.4.4 LAMEA Nebulizer Market by Country
6.4.4.1 Brazil Nebulizer Market
6.4.4.1.1 Brazil Nebulizer Market by Type
6.4.4.1.2 Brazil Nebulizer Market by End-use
6.4.4.1.3 Brazil Nebulizer Market by Application
6.4.4.2 Argentina Nebulizer Market
6.4.4.2.1 Argentina Nebulizer Market by Type
6.4.4.2.2 Argentina Nebulizer Market by End-use
6.4.4.2.3 Argentina Nebulizer Market by Application
6.4.4.3 UAE Nebulizer Market
6.4.4.3.1 UAE Nebulizer Market by Type
6.4.4.3.2 UAE Nebulizer Market by End-use
6.4.4.3.3 UAE Nebulizer Market by Application
6.4.4.4 Saudi Arabia Nebulizer Market
6.4.4.4.1 Saudi Arabia Nebulizer Market by Type
6.4.4.4.2 Saudi Arabia Nebulizer Market by End-use
6.4.4.4.3 Saudi Arabia Nebulizer Market by Application
6.4.4.5 South Africa Nebulizer Market
6.4.4.5.1 South Africa Nebulizer Market by Type
6.4.4.5.2 South Africa Nebulizer Market by End-use
6.4.4.5.3 South Africa Nebulizer Market by Application
6.4.4.6 Nigeria Nebulizer Market
6.4.4.6.1 Nigeria Nebulizer Market by Type
6.4.4.6.2 Nigeria Nebulizer Market by End-use
6.4.4.6.3 Nigeria Nebulizer Market by Application
6.4.4.7 Rest of LAMEA Nebulizer Market
6.4.4.7.1 Rest of LAMEA Nebulizer Market by Type
6.4.4.7.2 Rest of LAMEA Nebulizer Market by End-use
6.4.4.7.3 Rest of LAMEA Nebulizer Market by Application
Chapter 7. Company Profiles
7.1 Omron Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Koninklijke Philips N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Vectura Group plc (Philip Morris International, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.4.1 Partnerships, Collaborations, and Agreements:
7.4 Allied Healthcare Products, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Drive DeVilbiss Healthcare (Medical Depot, Inc.)
7.5.1 Company Overview
7.6 Beurer GmbH
7.6.1 Company Overview
7.7 GE HealthCare Technologies, Inc.
7.7.1 Company Overview
7.8 PARI GmbH
7.8.1 Company Overview
7.9 Aerogen Ltd.
7.9.1 Company Overview
Companies Mentioned
- Omron Corporation
- Koninklijke Philips N.V.
- Drive DeVilbiss Healthcare (Medical Depot, Inc.)
- Beurer GmBH
- Vectura Group Plc (Philip Morris International, Inc.)
- Allied Healthcare Products, Inc.
- GE HealthCare Technologies, Inc.
- PARI GmbH
- Aerogen Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 191 |
| Published | January 2023 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 945.9 Million |
| Forecasted Market Value ( USD | $ 1372.8 Million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
